Why did govx stock rise

GeoVax Labs, Inc. (GOVX) stock experienced a rise due to several factors:

1. BARDA Funding: The company received approximately $24.3 million from the Biomedical Advanced Research and Development Authority (BARDA) to fund the manufacturing of clinical materials for a Phase IIb trial of its COVID-19 vaccine. This funding announcement could have positively influenced investor sentiment.
2. Manufacturing Milestone: GeoVax achieved a significant milestone by releasing the first lot of its COVID-19 vaccine, GEO-CM04S1, produced with a commercial manufacturing platform. This marks the successful transfer and scale-up of manufacturing from research to commercial production, indicating progress towards the vaccine's potential market readiness.

These developments likely contributed to the increase in GOVX stock. However, it's important to consider that stock prices are influenced by a multitude of factors, and the rise in GOVX stock may also be subject to market dynamics and investor sentiment.